The conventional buffer manufacturing process is fraught with several challenges, including high cost of buffer production, time-consuming manufacturing process, batch-to-batch variations, and the need for large floor space. In order to deal with the aforementioned challenges, a number of pharmaceutical companies prefer to either install novel buffer manufacturing systems with advanced technologies in their manufacturing facility or outsource their buffer manufacturing requirements to specialized service providers.
The financial opportunity within the buffer preparation system market has been analyzed across the following segments:
- Scale of Operation
- Preclinical/ Clinical
- Commercial
- Type of System Component
- Single-use Buffer Mixing / Buffer Preparation Equipment
- Reusable Buffer Mixing / Preparation Equipment
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Rest of the World
The research includes profiles of the key players (listed below) engaged in this domain; each profile features a brief overview of the company, details on buffer manufacturing systems and services, recent developments and an informed future outlook.
- Asahi Kasei
- Avantor
- Canvax
- Cytiva
- Lonza
- Merck
- Pall Corporation
- Thermo Fisher Scientific
- Uniogen
Table of Contents
- Preface
2. Executive Summary
Introduction
- Market Landscape: Buffer Manufacturing Systems
- Product Competitiveness Analysis
- Company Profiles: Buffer Manufacturing System Providers
- Market Landscape: Buffer Manufacturing Service Providers
- Company Competitiveness Analysis
- Company Profiles: Buffer Manufacturing Service Providers
- Partnerships and Collaborations
- Market Forecast
- Conclusion
- Appendix I: Tabulated Data
- Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/buffer-preparation-market.html
Learn from experts: do you know about these emerging industry trends?
Viral Clearance and Viral Testing Services
Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
